What new GLP-1 and metabolic drugs are on the horizon (like orforglipron, higher-dose oral semaglutide, and GLP-1/amylin combos)
GLP-1 programs that are provided by physicians via telehealth indicate the increasing need in medically-monitored weight-loss programs
BCBS Michigan changed the prior authorization criteria for Zepbound (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide) from August 1, 2024, through December 31, 2024
10.1007/s00429-016-1196-y Brain Struct Funct
In doing so, we highlight the context-dependent plasticity of autophagy and how its regulatory architecture adapts dynamically to the metabolic, inflammatory, and redox environments of the cell
Readers should verify current details directly with the manufacturer, pharmacy and insurance provider